General Information of DTT (ID: TT1TYN7)

DTT Name Nuclear receptor ROR-alpha (RORA) DTT Info
Gene Name RORA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Preclinical Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9598431, 3 DMRC4O7 N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
2 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SR1078 DM7MDZE Liver cancer 2C12 Preclinical [2]
SR3335 DM96IUW Type-2 diabetes 5A11 Preclinical [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
7-hydroxycholesterol DMZXMB7 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Compounds useful for inhibiting ROR-gamma-t. US9598431.
2 Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and ROR. ACS Chem Biol. 2010 Nov 19;5(11):1029-34.
3 Identification of SR3335 (ML-176): a synthetic RORalpha selective inverse agonist. ACS Chem Biol. 2011 Mar 18;6(3):218-22.
4 Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach. Anal Biochem. 2003 Dec 1;323(1):139-49.